Relmada Therapeutics (RLMD) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 1

2 insiders bought $1.7M. No sales.

BuyMaged Shenouda$505KChief Financial Officerat $4.20 on Sep 9, filed Sep 11

BuyMaged ShenoudaChief Financial Officer$505Kat $4.20 on Sep 9, filed Sep 11

BuySergio Traversa$418KChief Executive Officerat $4.18 on Sep 9, filed Sep 11

BuySergio TraversaChief Executive Officer$418Kat $4.18 on Sep 9, filed Sep 11

BuySergio Traversa$410KChief Executive Officerat $4.10 on Sep 10, filed Sep 11

BuySergio TraversaChief Executive Officer$410Kat $4.10 on Sep 10, filed Sep 11

From SEC Form 4s, the newest filed Sep 11, 2026 · Insiders have 2 business days to file a trade

1 more filing on RLMD in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 4 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on RLMD with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Relmada Therapeutics

Insider trades by person

Cluster buys at RLMD

2 insiders bought RLMD in the last 6 months: Maged Shenouda and Sergio Traversa.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about RLMD's insider trades

As of Nov 2, 2026: Relmada Therapeutics (RLMD) has 4 insider filings on record in the last 6 months, the newest filed Sep 11, 2026. Its Quality Score is 1 (Below Average). Scores as of 8:57 PM ET, 15 minutes behind.

Are RLMD insiders buying or selling?

2 insiders bought $1.7M across 4 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Maged Shenouda, Chief Financial Officer, bought $505K on Sep 9, 2026. 2 insiders bought RLMD in the last 6 months: Maged Shenouda and Sergio Traversa.

Who are RLMD's biggest insider sellers?

No RLMD insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an RLMD insider last buy?

Maged Shenouda, Chief Financial Officer, bought RLMD shares ($505K) on Sep 9, 2026, filed Sep 11, 2026, the newest insider buy on record.

Relmada Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech. RLMD is on insider buys, Sep 7 to 13, 2026.